Treatment of osteonecrosis of the femoral head using prevascularized bone tissues constructed with human umbilical cord mesenchymal stem cells and human umbilical vein endothelial cells

Author:

ren qiang1ORCID,Chai Miaomiao2,Chen Kaijia3,Yuzhe GUO2,Yan ZHOU2,Ning CAO4,Yu Chenxi5ORCID

Affiliation:

1. Binzhou Medical University Hospital

2. East China University of Science and Technology

3. Binzhou Medical College Affiliated Hospital: Binzhou Medical University Hospital

4. China University of Petroleum Huadong

5. University of Hong Kong Li Ka Shing Faculty of Medicine

Abstract

Abstract Background: Studies have shown that osteonecrosis of the femoral head (ONFH)is related to bone marrow mesenchymal stem cell injury and microvascular injury. Early ONFH patients can choose core decompression and other treatments, but the clinical effect is poor. In recent years, tissue engineering technology based on mesenchymal stem cells is a new method to treat ONFH. In addition, whether the transplantation area is fully vascularized also affects whether the mesenchymal stem cells can play a repair role. In this study, we constructed prevascularized bone tissue based on human umbilical cord mesenchymal stem cells and human umbilical vein endothelial cells to evaluate the therapeutic effect of prevascularized bone tissue on ONFH. Objective: This paper is to investigate the effect of pre-vascularized bone tissue constructed by human umbilical cord mesenchymal stem cells and human umbilical vein endothelial cells on bone repair of necrotic femoral head, so as to provide theoretical basis for clinical treatment of necrotic femoral head. Methods: The rabbits were randomly divided into 5 groups, of which, 1 group was not given any intervention, while rabbit femoral head necrosis models were prepared for the other 4 groups by microwave heating method and they are respectively named mould-making group, static bone tissue group, dynamic bone tissue group and pre-vascularized bone tissue group according to the different substances injected into the femoral head. Various tests, including MRI, Micro-CT, HE staining and immunofluorescence staining, were performed after the animals were executed 8 weeks after treatment to assess the osteogenic ability of the implant and the repair effect of necrotic femoral head. Results: Various tests showed that the pre-vascularized bone tissue group had better ability to promote necrotic femoral head repair, and significant new bone formation and bone quality improvement occurred 8 weeks after surgery. The static bone tissue group and dynamic bone tissue group were similar in their ability to promote femoral head repair, with all the three groups outperforming the modeled group. Conclusions: The pre-vascularized bone tissue has a good effect on promoting the reconstruction of necrotic femoral head and shows superior osteogenesis, angiogenesis and bone repair effect. It is thus a good graft material for repairing necrotic femoral head and is of great value in the treatment of necrotic femoral head.

Publisher

Research Square Platform LLC

Reference31 articles.

1. Osteonecrosis of the Femoral Head: an Updated Review of ARCO on Pathogenesis, Staging and Treatment;HINES JT, JO WL;J Korean Med Sci,2021

2. Research progress in the pathogenesis of steroid-induced femoral head necrosis [J];Yi S;Chin J Orthop Surg 2023

3. Nontraumatic Osteonecrosis of the Femoral Head: Where Do We Stand Today?: A 5-Year Update;Mont MA;J Bone Joint Surg Am,2020

4. Tissue Engineering Strategies for Treating Avascular Necrosis of the Femoral Head;MURAB S;Bioeng (Basel),2021

5. Research progress of tissue engineering to promote the revascularization of femoral head necrotic tissue [J];Lin Miaoyuan Y;Chin J Prosthoplastic Surg

全球学者库

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"全球学者库"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前全球学者库共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2023 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3